Longevity Clinic Singapore
A doctor-led programme for measuring health risk, detecting disease earlier, supporting recovery and deciding which interventions are actually worth doing.
Longevity medicine is not one test or one device. The useful sequence is measurement, interpretation, action and re-measurement. We distinguish established prevention from promising but less certain interventions rather than presenting everything as equally proven.
Start with the clinical question
Some people come because they want a baseline. Others are concerned about cardiometabolic risk, cancer screening, recovery after illness or treatment, fertility, or preserving biological material for the future. The right pathway depends on the question—not on which test has the newest marketing.
What happens after testing?
Results are reviewed in context by a doctor. An abnormal number alone may be unimportant; a normal number may not remove risk. The value lies in deciding what changes, what does not, and when to measure again.
Know what is changing
Baseline biological-age, biomarker and cardiovascular-risk work helps turn longevity from a vague goal into something measurable.
Screen before symptoms
Screening can identify risk or signals earlier, but it is not diagnosis. Positive findings require appropriate confirmatory investigation.
Recovery-focused therapies
HBOT has established indications and other uses with more limited evidence. Each use should be considered on its own evidence and clinical context.
Preservation and restoration
Services involving biological material and the microbiome require especially clear discussion of what is established now versus what may become useful in the future.
Services that often overlap
These are useful adjacent services but are not currently listed inside the Aquila Longevity dropdown.
Not every intervention has the same evidence
Cardiometabolic risk assessment and management, appropriate cancer screening, and treating identifiable disease or deficiency remain the foundation.
Biological-age estimates can help track trends, but different clocks may disagree. They should support—not replace—clinical interpretation.
Some longevity interventions have plausible mechanisms but limited long-term human outcome data. We discuss that uncertainty explicitly.
Measure → interpret → act → re-measure
1. Assessment. Testing is selected according to age, history, current concerns and risk—not simply because it is available.
2. Interpretation. Results are reviewed together rather than as isolated red or green numbers.
3. Action. The plan may involve treatment, lifestyle change, further investigation, watchful follow-up—or no intervention.
4. Re-measurement. When useful, repeat testing is scheduled at an interval long enough to tell whether anything changed.
Start with your risk profile, not a package.
Tell us what you are trying to understand—baseline health, biological age, cancer risk, recovery, fertility or future planning—and we can decide which pathway is worth exploring.
This page is educational and does not replace an individual medical consultation. Screening tests can produce false-positive and false-negative results, and no assessment can predict or guarantee lifespan or healthspan. Suitability depends on age, medical history, current health and risk profile. Content reviewed by the medical team at Aquila Medical Center, Singapore. Last reviewed: 28 August 2026.